Objective-To identify cases of inherited prion diseases in Britain and to assess their phenotypic features.
Introduction
The human transmissible spongiform encephalopathies have been traditionally classified as CreutzfeldtJakob disease, Gerstmann-Strdussler syndrome, and kuru. Although these disorders are transmissible, 15% of cases of Creutzfeldt-Jakob disease are familial and Gerstmann-Straussler syndrome is usually familial.' Studies of genetic linkage have shown that familial Creutzfeldt-Jakob disease and Gerstmann-Straussler syndrome are autosomal dominant conditions,2 and several mutations in the prion protein gene on chromosome 20p have now been identified in both conditions.3 DNA diagnosis has shown that these conditions have a larger phenotypic range than previously realised.4
They form part of a range of diseases now more logically termed inherited prion diseases, and a new nomenclature has been proposed. 5 A 100-fold excess incidence of Creutzfeldt-Jakob disease among Iibyan Jews was previously attributed to their eating lightly cooked sheep's brain and eyeballs.6 Both this cluster of disease7 and another cluster in Slovakia' are now known to be genetic in origin and associated with a missense mutation at codon 200 of the prion protein gene causing substitution of lysine in place of glutamate at residue 200 of the prion protein (inherited prion disease (PrP lysine 200)). In contrast to the other inherited prion diseases, this variant presents clinically like classic sporadic CreutzfeldtJakob disease, with a rapidly progressive dementia and myoclonus; pyramidal, cerebellar, or extrapyramidal signs; periodic complexes of 1-2 cycles/second in an electroencephalogram; and a short duration of disease (less than 12 months). Histological examination uniformly shows the classic features of spongiform encephalopathies: spongiform change, astrocytic proliferation, and neuronal loss.7 The relative phenotypic homogeneity of this disease may, however, be the result of selection bias, and now that a DNA marker is available more variability may become apparent, as is seen in the other inherited prion diseases. Homozygotes for the mutation at codon 200 do not seem to differ clinically from heterozygotes, which indicates that inherited prion disease (PrP lysine 200) is a fully dominant disorder. 7 While screening patients suspected of having Creutzfeldt-Jakob disease and other presenile dementias for mutations in the prion protein gene we identified a British patient with inherited prion disease (PrP lysine 200), which suggests a further focus of this disorder.
Methods
DNA was extracted from peripheral blood with standard techniques. The coding sequence of the prion protein gene was amplified by the polymerase chain reaction with synthetic oligonucleotide primers flanking the open reading frame. Products of the chain reaction were fractionated by size in agarose gels to detect the presence of insertions or deletions. The products were also immobilised on nylon membranes, and the presence of known point mutations or polymorphisms was assessed by sequential hybridisation with allele specific oligonucleotides labelled with phosphorus-32 as described previously.4
Case reports A 58 year old man was well until May 1989, when he noticed pain in the front of both shins radiating into the feet. He We also investigated a British patient of Libyan Jewish ancestry who presented with symptoms characteristic of Creutzfeldt-Jakob disease. Results of histological examination of the brain were diagnostic of the disease.
Both patients described were heterozygous for the missense mutation at codon 200 of the prion protein gene. No other pathogenic mutation (insertions or missense mutations at codons 102, 117, 178, 198, and 217) was present. Both patients were homozygous for methionine at codon 129.
Discussion
We have identified a British family and a further patient of Libyan Jewish ancestry with inherited prion disease (PrP lysine 200). The clinical presentation of those affected and the course of the disease were characteristic of sporadic Creutzfeldt-Jakob disease; the other inherited prion diseases so far described generally present as an illness similar to GerstmannStraussler syndrome with a much longer duration or as atypical dementia.49
The patient reported on in detail was of British origin with no evidence of either Libyan Jewish or central European ancestry, suggesting a separate, British focus of this disease. Whether these three foci have a common origin or arise from different mutational events is unknown. Interestingly, both patients reported on were homozygous for methionine at codon 129. Homozygosity for either allele of this common polymorphism is associated with earlier onset of inherited disease and predisposes the person to sporadic Creutzfeldt-Jakob disease.'112 Some people from both the Libyan Jewish and Slovakian foci of inherited prion disease have been found to carry the mutation at codon 200 and yet remain unaffected at ages similar to or greater than the upper age at onset in most affected relatives.78 Such incomplete penetrance has not been reported in other types of inherited prion disease. These carriers of non-penetrant or late onset genes may be heterozygous at codon 129 since heterozygosity at codon 129 might be expected to delay or protect against the onset of clinical disease. Whether heterozygosity is protective could have an important bearing on genetic counselling in this disease now that presymptomatic detection of this and other mutations in the prion protein gene is possible. '3 We thank Dr G Stem for referring patients and the Wellcome Trust, Agricultural and Food Research Council, and Brain Research Trust for financial support.
